BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21839543)

  • 21. Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons.
    Kowada A
    Epidemiol Infect; 2013 Oct; 141(10):2224-34. PubMed ID: 23286364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of QuantiFERON-TB Gold assay and chest computed tomography in a tuberculosis outbreak.
    Lew WJ; Jung YJ; Song JW; Jang YM; Kim HJ; Oh YM; Lee SD; Kim WS; Kim DS; Kim WD; Shim TS
    Int J Tuberc Lung Dis; 2009 May; 13(5):633-9. PubMed ID: 19383198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.
    Schoepfer AM; Flogerzi B; Fallegger S; Schaffer T; Mueller S; Nicod L; Seibold F
    Am J Gastroenterol; 2008 Nov; 103(11):2799-806. PubMed ID: 18684188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
    Mazurek GH; Zajdowicz MJ; Hankinson AL; Costigan DJ; Toney SR; Rothel JS; Daniels LJ; Pascual FB; Shang N; Keep LW; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):826-36. PubMed ID: 17806046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in Bacille Calmette-Guérin vaccinated children.
    Chun JK; Kim CK; Kim HS; Jung GY; Lee TJ; Kim KH; Kim DS
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):389-94. PubMed ID: 18990532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preventive measures against tuberculosis in working facilities and companies].
    Suzuki K; Satou K
    Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
    Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa.
    Moyo S; Isaacs F; Gelderbloem S; Verver S; Hawkridge AJ; Hatherill M; Tameris M; Geldenhuys H; Workman L; Pai M; Hussey G; Hanekom WA; Mahomed H
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1176-81, i. PubMed ID: 21943841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost-effectiveness analysis of QuantiFERON-TB 2nd generation used for detection of tuberculosis infection in contact investigations].
    Mori T; Harada N
    Kekkaku; 2005 Nov; 80(11):675-86. PubMed ID: 16363672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
    Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E
    Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma release assay clarifies the effect of bacille Calmette-Guérin vaccination in Greek army recruits.
    Katsenos S; Nikolopoulou M; Konstantinidis AK; Gartzonika C; Gogali A; Margelis I; Tatsioni A; Mavridis A; Constantopoulos SH; Daskalopoulos G
    Int J Tuberc Lung Dis; 2010 May; 14(5):545-50. PubMed ID: 20392346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
    Kawabe Y
    Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the QuantiFERON-TB blood assay a good replacement for the tuberculin skin test in tuberculosis screening? a pilot study at Berkshire Medical Center.
    Zhao X; Mazlagic D; Flynn EA; Hernandez H; Abbott CL
    Am J Clin Pathol; 2009 Nov; 132(5):678-86. PubMed ID: 19846807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole blood interferon-γ release assay is a useful tool for the diagnosis of tuberculosis infection particularly among Bacille Calmette Guèrin-vaccinated children.
    Tsolia MN; Mavrikou M; Critselis E; Papadopoulos NG; Makrinioti H; Spyridis NP; Metsou F; Tsagaraki M; Koulouri M; Kafetzis DA
    Pediatr Infect Dis J; 2010 Dec; 29(12):1137-40. PubMed ID: 20616761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of interferon-gamma release assay conversion following tuberculin skin testing.
    Ritz N; Yau C; Connell TG; Tebruegge M; Leslie D; Curtis N
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):767-9. PubMed ID: 21575296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.